Charles Zhu
Stock Analyst at LifeSci Capital
(1.63)
# 1447
Out of 5,347 analysts
26
Total ratings
50.00%
Success rate
23.31%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RPTX Repare Therapeutics | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Dec 13, 2024 | |
TNGX Tango Therapeutics | Maintains: Buy | 18 8 | 2.21 | 261.99% | 3 | Nov 7, 2024 | |
MGNX Macrogenics | Upgrades: Buy | 12 | 1.36 | 782.35% | 4 | Nov 7, 2023 | |
MRUS Merus | Maintains: Strong Buy | 46 48 | 56.05 | -14.36% | 6 | Aug 8, 2023 | |
NUVL Nuvalent | Initiates Coverage On: Buy | 56 | 74.53 | -24.86% | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 22 | 3.04 | 623.68% | 1 | Jul 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 26 | 5.45 | 377.06% | 3 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 32 | 19.89 | 60.88% | 3 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 14 | 11.43 | 22.48% | 2 | May 5, 2022 |